By Rebecca Melvin
New York, May 19 – Repligen Corp. priced $100 million of five-year convertible senior notes early Thursday at par to yield 2.125% with an initial conversion premium of 22.5%, according to a news release.
The registered, off-the-shelf deal priced at the cheap end of talk, which was for a 1.625% to 2.125% coupon and a 22.5% to 27.5% premium.
The offering has a $15 million greenshoe and was being sold via Jefferies & Co. as bookrunner. Perella Weinberg Partners LP and J. Wood Capital Advisors LLC were financial advisers to the company in connection with the offering.
The notes are non-callable for three years. They have contingent conversion and takeover protection. The company may settle the bonds in cash, shares or a combination of shares and cash at its option.
Proceeds are earmarked for working capital and other general corporate purposes, including possible acquisitions and investments.
Waltham, Mass.-based Repligen is a bioprocessing company focused on the development, production and commercialization of products used in the production of monoclonal antibodies, recombinant proteins and vaccines.
Issuer: | Repligen Corp.
|
Issue: | Convertible senior notes
|
Amount: | $100 million
|
Greenshoe: | $15 million
|
Maturity: | June 1, 2021
|
Bookrunner: | Jefferies & Co.
|
Co-managers: | Janney Montgomery Scott LLC, Craig-Hallum Capital Group
|
Coupon: | 2.125%
|
Price: | Par
|
Yield: | 2.125%
|
Conversion premium: | 22.5%
|
Conversion price: | $32.07
|
Conversion ratio: | 31.1813
|
Calls: | Non-callable until June 5, 2019
|
Puts: | No puts
|
Contingent conversion: | Yes
|
Takeover protection: | Yes
|
Net share settlement: | Yes
|
Pricing date: | May 19
|
Settlement date: | May 24
|
Distribution: | Registered, off the shelf
|
Price talk: | 1.625%-2.125%, up 22.5%-27.5%
|
Stock symbol: | Nasdaq: RGEN
|
Stock price: | $26.18 at close May 18
|
Market capitalization: | $810 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.